Compare INCR & FLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INCR | FLYX |
|---|---|---|
| Founded | 1994 | 2015 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.3M | 79.8M |
| IPO Year | N/A | N/A |
| Metric | INCR | FLYX |
|---|---|---|
| Price | $1.18 | $3.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 46.0K | 14.9K |
| Earning Date | 10-08-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $72,158,312.00 | ★ $362,955,000.00 |
| Revenue This Year | $69.54 | $28.47 |
| Revenue Next Year | $41.75 | $22.44 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 16.38 |
| 52 Week Low | $1.22 | $1.90 |
| 52 Week High | $1.79 | $6.90 |
| Indicator | INCR | FLYX |
|---|---|---|
| Relative Strength Index (RSI) | 37.69 | 44.48 |
| Support Level | $1.35 | $3.08 |
| Resistance Level | $1.51 | $3.46 |
| Average True Range (ATR) | 0.07 | 0.35 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 13.90 | 10.53 |
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.
flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 100 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.